SHAMBHAVI IS ADMITTED IN APOLLO CANCER HOSPITAL, TEYNAMPET ON 03RD APRIL 2022 FOR DE- SENSITISATION PROTOCOL.ON EACH MONDAY PLASMAPHERESIS THEN TUESDAY BORTIZOMIB AND RITUXIMAB FOLLOWING WEDNESDAY TO SUNDAY DESFERAL .THIS DE SENSITISATION PROTOCOL CONTINUES TILL HER PRA REPORT BECOMES NEGATIVE
IF NO FULLY MATCHED FAMILY OR UNRELATED DONOR AVAILABLE THEN
WISH TO PROCEED WITH HAPOIDENTICAL HSCT - IN VIEW OF POSITIVE PRA DE-SENSITISATION WITH RITUXIMAB/BORTEZOMIB/PLASMAPHERESIS FOLLOWED BY PTIS -2 CYCLES FOLLOWED BY HSCT -IT CARRIES 50% CHANCE OF REJECTION EVEN WITH ALL THESE MEASURES.